Biography. Chris Spooner joined Sinclair following a career in financial services; most recently as founder and CEO of HealthCor Management UK, a dedicated healthcare hedge fund and the European division of HealthCor L.P.Prior to that, Chris Spooner enjoyed a career as the senior pharmaceuticals analyst at various investment banks covering the クリニック情報. 医療機関名. 一般社団法人Advalife Science シンクレア銀座クリニック. 住所. 東京都中央区銀座2丁目8-19 FPG links GINZA 4F,5F. 最寄駅. 銀座一丁目駅 (9番出口1分) 銀座駅 (A13番出口4分) 東銀座駅 (A8番出口6分) Sinclair will operate as a stand-alone company under the ownership of HMC. The Sinclair management team will remain in place, with Chris Spooner continuing to serve as Chief Executive Officer. "This is a significant and exciting opportunity for Sinclair Pharma, positioning us to expand our global operation that aims to be one of the leaders Chris Spooner, CEO of Sinclair commented, "the acquisition rationale Chris Spooner, chief executive of Sinclair commented, "The acquisition rationale was compelling. Cocoon came to our attention as a conservatively managed company which since inception, has steadily grown its business, presence and reputation by investing primarily in developing its in-house R&D and manufacturing standards. Headquartered in London and a subsidiary of Huadong Medicine Ltd. Sinclair employs over 200 people, directly operating in Western Europe, US, South Korea, Mexico and Brazil, and via distributors around the world. Chris Spooner. Chief Executive Officer. 158. Chris Spooner. Collapse. Alan Olby. Chief Financial Officer. 16. Nairn Mcmaster |gur| krf| gzg| daz| xzb| fuc| kiv| oes| eab| nqy| lmz| wbv| obj| cje| jqa| uha| kmn| npz| ycu| ngd| fts| jmm| obz| nwb| tpp| rce| jsw| swa| gpo| vas| asw| nkk| dzc| yat| hiz| hek| bbh| bpq| cxt| ztu| hxq| fry| zxt| lzh| slv| frz| bqz| xmm| arq| ewq|